应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
00867 康哲药业
中秋节翌日休市 09-17 16:08:15
7.620
+0.060
+0.79%
最高
7.620
最低
7.400
成交量
211.10万
今开
7.490
昨收
7.560
日振幅
2.91%
总市值
185.89亿
流通市值
185.89亿
总股本
24.40亿
成交额
1,596万
换手率
0.09%
流通股本
24.40亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
南向资金9月13日净买入康哲药业66.30万股 连续3日增持
市场透视 · 09-16 09:30
南向资金9月13日净买入康哲药业66.30万股 连续3日增持
康哲药业(00867)上涨5.01%,报7.54元/股
金融界 · 09-13
康哲药业(00867)上涨5.01%,报7.54元/股
康哲药业盘中异动 下午盘大幅上涨5.01%报7.540港元
市场透视 · 09-13
康哲药业盘中异动 下午盘大幅上涨5.01%报7.540港元
Treasure Sea Limited增持康哲药业(00867)50万股 每股作价约7.12港元
智通财经 · 09-05
Treasure Sea Limited增持康哲药业(00867)50万股 每股作价约7.12港元
Treasure Sea Limited增持康哲药业(00867)50万股 每股作价约7.07港元
智通财经 · 09-04
Treasure Sea Limited增持康哲药业(00867)50万股 每股作价约7.07港元
康哲药业09月04日遭主力抛售445万元 环比增加1335.48%
市场透视 · 09-04
康哲药业09月04日遭主力抛售445万元 环比增加1335.48%
Treasure Sea Limited增持康哲药业(00867)50万股 每股作价约7.17港元
智通财经 · 09-02
Treasure Sea Limited增持康哲药业(00867)50万股 每股作价约7.17港元
康哲药业08月29日遭主力抛售148万元 环比增加138.71%
市场透视 · 08-29
康哲药业08月29日遭主力抛售148万元 环比增加138.71%
迈进新产品时代,康哲药业(00867.HK)加速创新成果兑现
格隆汇 · 08-27
迈进新产品时代,康哲药业(00867.HK)加速创新成果兑现
南向资金8月23日净买入康哲药业47.20万股 连续3日增持
市场透视 · 08-26
南向资金8月23日净买入康哲药业47.20万股 连续3日增持
【券商聚焦】海通国际升康哲药业(00867)目标价0.6% 料独家产品收入占比持续提升 转型有望逐步兑现
金吾资讯 · 08-20
【券商聚焦】海通国际升康哲药业(00867)目标价0.6% 料独家产品收入占比持续提升 转型有望逐步兑现
《大行》大摩降康哲药业(00867.HK)目标价至11元 评级“增持”
阿斯达克财经 · 08-20
《大行》大摩降康哲药业(00867.HK)目标价至11元 评级“增持”
《大行》海通国际轻微上调康哲药业(00867.HK)目标价至9.96元 集采影响基本消化
阿斯达克财经 · 08-20
《大行》海通国际轻微上调康哲药业(00867.HK)目标价至9.96元 集采影响基本消化
康哲药业(00867.HK):国采风险基本出尽 创新产品逐步放量
中金公司 · 08-17
康哲药业(00867.HK):国采风险基本出尽 创新产品逐步放量
医美概念股全线上扬 康哲药业(00867)涨9.47% 机构指医美类差异化上游厂商抢占市场能力更强
金吾财讯 · 08-16
医美概念股全线上扬 康哲药业(00867)涨9.47% 机构指医美类差异化上游厂商抢占市场能力更强
康哲药业上半年盈利同比下降52.8% 公司称国采的负面影响已基本消化
每日经济新闻 · 08-16
康哲药业上半年盈利同比下降52.8% 公司称国采的负面影响已基本消化
康哲药业(00867)2024年中期营业额和利润环比均稳步提升 迈入"新产品时代"
美通社 · 08-16
康哲药业(00867)2024年中期营业额和利润环比均稳步提升 迈入"新产品时代"
康哲药业(00867.HK)绩后曾升11% 中期溢利较去年下半年增长近93%
阿斯达克财经 · 08-16
康哲药业(00867.HK)绩后曾升11% 中期溢利较去年下半年增长近93%
康哲药业(00867)股价显著上升11.128%,现价港币$7.39
阿斯达克财经 · 08-16
康哲药业(00867)股价显著上升11.128%,现价港币$7.39
康哲药业(00867)上涨10.08%,报7.32元/股
金融界 · 08-16
康哲药业(00867)上涨10.08%,报7.32元/股
暂无数据
公司概况
公司名称:
康哲药业
所属市场:
SEHK
上市日期:
--
主营业务:
康哲药业控股有限公司是一家主要从事医药产品的制造、推广、营销及销售业务的香港投资控股公司。其直接网络主要产品包括黛力新、优思弗、新活素、莎尔福、亿活及施图伦滴眼液等。其代理商推广网络产品包括沙多力卡、伊诺舒及喜达康等。其产品用于治疗胃病、心脏病、外伤感染、肝病及眼疾等。
发行价格:
--
{"stockData":{"symbol":"00867","market":"HK","secType":"STK","nameCN":"康哲药业","latestPrice":7.62,"timestamp":1726560495009,"preClose":7.56,"halted":0,"volume":2111000,"delay":0,"floatShares":2439528512,"shares":2439528512,"eps":1.0749763,"marketStatus":"中秋节翌日休市","marketStatusCode":7,"change":0.06,"latestTime":"09-17 16:08:15","open":7.49,"high":7.62,"low":7.4,"amount":15957779,"amplitude":0.029101,"askPrice":7.62,"askSize":6000,"bidPrice":7.6,"bidSize":35000,"shortable":3,"etf":0,"ttmEps":0.6242202746375682,"exchange":"SEHK","tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1726709400000},"adr":0,"adjPreClose":7.56,"dividendRate":0.03294,"openAndCloseTimeList":[[1726536600000,1726545600000],[1726549200000,1726560000000]],"volumeRatio":0.3354809944126463,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/00867/tweets","defaultTab":"tweets","newsList":[{"id":"2467857693","title":"南向资金9月13日净买入康哲药业66.30万股 连续3日增持","url":"https://stock-news.laohu8.com/highlight/detail?id=2467857693","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2467857693?lang=zh_cn&edition=full","pubTime":"2024-09-16 09:30","pubTimestamp":1726450207,"startTime":"0","endTime":"0","summary":"9月13日, 南向资金增持康哲药业66.30万股,连续3日增持。截止当日收盘,港股通共持有康哲药业21467.82万股,占流通股8.79%。康哲药业近5个交易日上涨5.20%,港股通累计增持3.60万股;近20个交易日上涨12.63%,港股通累计增持411.70万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409160930319567fa64&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409160930319567fa64&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2488822045.USD","SG9999004220.SGD","BK1593","SG9999015945.SGD","SG9999015986.USD","IE00BYV24P56.USD","SG9999015978.USD","SG9999015952.SGD","00867","BK1191","IE00BMCWC346.EUR"],"gpt_icon":0},{"id":"2467812792","title":"康哲药业(00867)上涨5.01%,报7.54元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2467812792","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2467812792?lang=zh_cn&edition=full","pubTime":"2024-09-13 13:36","pubTimestamp":1726205819,"startTime":"0","endTime":"0","summary":"9月13日,康哲药业盘中上涨5.01%,截至13:36,报7.54元/股,成交3286.56万元。康哲药业控股有限公司主要业务是与全球生物科技和制药公司合作,开发全球首创和同类最优的创新产品,专注于心脑血管、消化、中枢神经、皮肤/医美、眼科、儿科等专科疾病领域。截至2024年中报,康哲药业营业总收入36.11亿元、净利润9.1亿元。9月12日,林刚于2024-09-12增持50万股,每股均价7.1499港元,最新持股数目11.64亿股,最新持股比例47.72%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/09/13133643245098.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["00867","BK1593","SG9999004220.SGD","SG9999015978.USD","BK1191","SG9999015945.SGD","SG9999015986.USD","LU2488822045.USD","SG9999015952.SGD","IE00BMCWC346.EUR","IE00BYV24P56.USD"],"gpt_icon":0},{"id":"2467279266","title":"康哲药业盘中异动 下午盘大幅上涨5.01%报7.540港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2467279266","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2467279266?lang=zh_cn&edition=full","pubTime":"2024-09-13 13:36","pubTimestamp":1726205816,"startTime":"0","endTime":"0","summary":"2024年09月13日下午盘13时36分,康哲药业股票出现波动,股价急速上涨5.01%。截至发稿,该股报7.540港元/股,成交量442.588万股,换手率0.18%,振幅5.57%。资金方面,该股资金流入1800.05万港元,流出1178.14万港元。康哲药业股票所在的药品行业中,整体涨幅为0.48%。消息层面,截至13时36分,康哲药业股票正面舆情新闻比例100%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409131336569719b3bd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409131336569719b3bd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SG9999015978.USD","SG9999015986.USD","SG9999015945.SGD","IE00BYV24P56.USD","IE00BMCWC346.EUR","BK1593","00867","BK1191","SG9999015952.SGD","LU2488822045.USD","SG9999004220.SGD"],"gpt_icon":0},{"id":"2465854318","title":"Treasure Sea Limited增持康哲药业(00867)50万股 每股作价约7.12港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2465854318","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2465854318?lang=zh_cn&edition=full","pubTime":"2024-09-05 20:21","pubTimestamp":1725538894,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,香港联交所最新资料显示,9月5日,Treasure Sea Limited增持康哲药业(00867)50万股,每股作价7.1196港元,总金额为355.98万港元。增持后最新持股数目约为11.621亿股,最新持股比例为47.63%。本交易涉及其他关联方:林刚。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1179972.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["SG9999015945.SGD","SG9999015986.USD","SG9999004220.SGD","BK1593","SG9999015978.USD","LU2488822045.USD","00867","BK1191","SG9999015952.SGD"],"gpt_icon":0},{"id":"2464937662","title":"Treasure Sea Limited增持康哲药业(00867)50万股 每股作价约7.07港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2464937662","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2464937662?lang=zh_cn&edition=full","pubTime":"2024-09-04 19:38","pubTimestamp":1725449936,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,香港联交所最新资料显示,9月4日,Treasure Sea Limited增持康哲药业(00867)50万股,每股作价7.0746港元,总金额为353.73万港元。增持后最新持股数目约为11.62亿股,最新持股比例为47.61%。本交易涉及其他关联方:林刚。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1179388.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1593","SG9999015978.USD","LU2488822045.USD","SG9999004220.SGD","SG9999015945.SGD","SG9999015952.SGD","BK1191","00867","SG9999015986.USD"],"gpt_icon":0},{"id":"2464799347","title":"康哲药业09月04日遭主力抛售445万元 环比增加1335.48%","url":"https://stock-news.laohu8.com/highlight/detail?id=2464799347","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2464799347?lang=zh_cn&edition=full","pubTime":"2024-09-04 16:15","pubTimestamp":1725437721,"startTime":"0","endTime":"0","summary":"09月04日, 康哲药业股价跌0.14%,报收7.10元,成交金额3449万元,换手率0.20%,振幅3.23%,量比1.00。康哲药业今日主力资金净流出445万元,上一交易日主力净流出31万元,今日环比增加1335.48%。该股近5个交易日上涨1.48%,主力资金累计净流出343万元,其中1个交易日为股价下跌时净流入;近20日主力资金累计净流入689万元,其中净流入天数为7日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409041615399edf0932&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409041615399edf0932&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["00867","SG9999004220.SGD","SG9999015978.USD","BK1593","SG9999015952.SGD","SG9999015945.SGD","BK1191","SG9999015986.USD","LU2488822045.USD"],"gpt_icon":0},{"id":"2464332168","title":"Treasure Sea Limited增持康哲药业(00867)50万股 每股作价约7.17港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2464332168","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2464332168?lang=zh_cn&edition=full","pubTime":"2024-09-02 19:25","pubTimestamp":1725276348,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,香港联交所最新资料显示,9月2日,Treasure Sea Limited增持康哲药业(00867)50万股,每股作价7.1688港元,总金额为358.44万港元。增持后最新持股数目约为11.61亿股,最新持股比例为47.57%。本交易涉及其他关联方:林刚。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1178269.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["00867","SG9999015978.USD","SG9999015952.SGD","LU2488822045.USD","SG9999015945.SGD","SG9999004220.SGD","BK1593","SG9999015986.USD","BK1191"],"gpt_icon":0},{"id":"2463528362","title":"康哲药业08月29日遭主力抛售148万元 环比增加138.71%","url":"https://stock-news.laohu8.com/highlight/detail?id=2463528362","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2463528362?lang=zh_cn&edition=full","pubTime":"2024-08-29 16:15","pubTimestamp":1724919349,"startTime":"0","endTime":"0","summary":"08月29日, 康哲药业股价涨2.19%,报收7.18元,成交金额3365万元,换手率0.19%,振幅3.84%,量比0.92。康哲药业今日主力资金净流出148万元,上一交易日主力净流出62万元,今日环比增加138.71%。该股近5个交易日上涨3.66%,主力资金累计净流出200万元;近20日主力资金累计净流入1348万元,其中净流入天数为8日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024082916163595cf2891&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024082916163595cf2891&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["00867","SG9999004220.SGD","SG9999015978.USD","BK1593","SG9999015952.SGD","SG9999015945.SGD","BK1191","SG9999015986.USD","LU2488822045.USD"],"gpt_icon":0},{"id":"2462238188","title":"迈进新产品时代,康哲药业(00867.HK)加速创新成果兑现","url":"https://stock-news.laohu8.com/highlight/detail?id=2462238188","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2462238188?lang=zh_cn&edition=full","pubTime":"2024-08-27 11:42","pubTimestamp":1724730170,"startTime":"0","endTime":"0","summary":"政策利好催化和融资环境转好,正使得创新药行业投资价值不断凸显,有望迎来布局机遇。","market":"sg","thumbnail":"https://img7.gelonghui.com/column/5.png","type":0,"news_type":0,"thumbnails":["https://img7.gelonghui.com/column/5.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/962445","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_highlight","symbols":["SG9999015945.SGD","SG9999015986.USD","SG9999004220.SGD","BK1593","SG9999015978.USD","LU2488822045.USD","00867","BK1191","SG9999015952.SGD"],"gpt_icon":0},{"id":"2462042981","title":"南向资金8月23日净买入康哲药业47.20万股 连续3日增持","url":"https://stock-news.laohu8.com/highlight/detail?id=2462042981","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2462042981?lang=zh_cn&edition=full","pubTime":"2024-08-26 09:30","pubTimestamp":1724635809,"startTime":"0","endTime":"0","summary":"8月23日, 南向资金增持康哲药业47.20万股,连续3日增持。截止当日收盘,港股通共持有康哲药业21288.62万股,占流通股8.72%。康哲药业近5个交易日下跌4.29%,港股通累计增持223.90万股;近20个交易日上涨7.96%,港股通累计增持595.40万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408260930429f580ad5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408260930429f580ad5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1593","00867","SG9999015986.USD","SG9999015952.SGD","SG9999004220.SGD","LU2488822045.USD","SG9999015978.USD","SG9999015945.SGD","BK1191"],"gpt_icon":0},{"id":"2460680026","title":"【券商聚焦】海通国际升康哲药业(00867)目标价0.6% 料独家产品收入占比持续提升 转型有望逐步兑现","url":"https://stock-news.laohu8.com/highlight/detail?id=2460680026","media":"金吾资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460680026?lang=zh_cn&edition=full","pubTime":"2024-08-20 16:03","pubTimestamp":1724141035,"startTime":"0","endTime":"0","summary":"金吾财讯 | 海通国际发研报指,康哲药业 上半年公司营收42.9亿元,环比+8.9%。该行表示,考虑到公司整体收入以及净利润环比2023年H2均呈现增长趋势,该行认为在2024H1,3款产品收入受到的集采负面影响已基本消化充分。公司预计,三个国采品种中,优思弗在24年H2还会面临5%的降价,降价幅度有限。该行认为,非国采独家产品竞争格局相对良好,未来将保持一定增长。公司独家产品和创新产品收入占比将持续提升,转型有望逐步兑现。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408201604089f3cffc9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408201604089f3cffc9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["00867"],"gpt_icon":0},{"id":"2460104497","title":"《大行》大摩降康哲药业(00867.HK)目标价至11元 评级“增持”","url":"https://stock-news.laohu8.com/highlight/detail?id=2460104497","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460104497?lang=zh_cn&edition=full","pubTime":"2024-08-20 14:04","pubTimestamp":1724133840,"startTime":"0","endTime":"0","summary":"摩根士丹利发表研究报告指,康哲药业(00867.HK) 的核心产品Ursofalk和Plendil于7月再度降价,该行将集团2024至26年的销售预测分别下调1.6%、3.1%和3.3%。而其他收益及收入及联营公司业绩增加,部分抵销了管理层指引中上升的营运开支。大摩将康哲药业2024的净利润预测上调0.1%,并将2025至26年的预测下调2.1%及0.2%。该行将集团目标价由12.5元降至11元,维持“增持”评级。(sl/k)(港股报价延迟最少十五分钟。沽空资料截至 2024-08-20 12:25。)AASTOCKS新闻","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20230303150407041_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20230303150407041_s.jpg"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1373159/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["00867"],"gpt_icon":0},{"id":"2460013101","title":"《大行》海通国际轻微上调康哲药业(00867.HK)目标价至9.96元 集采影响基本消化","url":"https://stock-news.laohu8.com/highlight/detail?id=2460013101","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460013101?lang=zh_cn&edition=full","pubTime":"2024-08-20 09:33","pubTimestamp":1724117580,"startTime":"0","endTime":"0","summary":"海通国际发表报告指,康哲药业受集采影响基本消化。2022至2023年执行的第七批和第八批集采分别涉及黛力新、波依定及优思弗三款原研药。考虑到公司整体收入以及净利润与去年下半年相比均呈现增长趋势,该行认为上半年3款产品收入受到的集采负面影响已基本消化充分。该行维持康哲药业“优于大市”评级,轻微上调目标价由9.9元升9.96元。","market":"other","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20230303150405882_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20230303150405882_s.jpg"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1373027/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["00867"],"gpt_icon":0},{"id":"2460927026","title":"康哲药业(00867.HK):国采风险基本出尽 创新产品逐步放量","url":"https://stock-news.laohu8.com/highlight/detail?id=2460927026","media":"中金公司","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460927026?lang=zh_cn&edition=full","pubTime":"2024-08-17 11:01","pubTimestamp":1723863705,"startTime":"0","endTime":"0","summary":"根据公告,1H24 黛力新、优思弗和波依定全按药品销售额计算收入合计为12.0 亿元,同比-49.2%。管理层表示优思弗和波依定下半年还有少量降价,但三个存量集采品种今明年依然能做到保留50%销售额的目标。根据公告,康哲药业上半年收入利润环比均呈现增长态势,国采对公司的负面影响已基本消化;我们预计公司后续主要由非国采独家产品和创新产品驱动业绩增长。创新品类推进情况符合预期。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408171101479f32c284&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408171101479f32c284&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SG9999015945.SGD","SG9999015986.USD","SG9999004220.SGD","BK1593","SG9999015978.USD","LU2488822045.USD","00867","BK1191","SG9999015952.SGD"],"gpt_icon":0},{"id":"2459250009","title":"医美概念股全线上扬 康哲药业(00867)涨9.47% 机构指医美类差异化上游厂商抢占市场能力更强","url":"https://stock-news.laohu8.com/highlight/detail?id=2459250009","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459250009?lang=zh_cn&edition=full","pubTime":"2024-08-16 14:26","pubTimestamp":1723789603,"startTime":"0","endTime":"0","summary":"金吾财讯 | 医美概念股全线上扬,康哲药业(00867)涨9.47%,现代牙科(03600)涨4.93%,四环医药(00460)涨3.85%,医思健康(02138)涨2.86%,复星医药(02196)涨2.6%,瑞尔集团(06639)涨2.27%,昊海生物科技(06826)涨1.95%。开源证券研报指出,建议关注医美、化妆品行业的投资机会。医美类差异化上游厂商抢占市场能力更强,长期看“渗透率+国产化率+合规化程度”多维提升逻辑未变;化妆品行业温和复苏,机会与挑战并存,把握渠道、成分、品类等细分结构性机会且综合竞争力强劲的国货美妆品牌有望在变化中抢占市场。","market":"other","thumbnail":"https://static.szfiu.com/news/20210810/OWNjYzkwNTM4YzEwMTc4NjgyODQzNQ==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/OWNjYzkwNTM4YzEwMTc4NjgyODQzNQ==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"1942461","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2488822045.USD","06639","03600","SG9999015978.USD","SG9999015952.SGD","BK1600","BK1161","BK1583","BK1511","SG9999015945.SGD","BK1100","00460","BK1191","06826","02138","BK1593","BK1219","BK1215","BK1515","SG9999004220.SGD","SG9999015986.USD","02196","00867"],"gpt_icon":0},{"id":"2459792250","title":"康哲药业上半年盈利同比下降52.8% 公司称国采的负面影响已基本消化","url":"https://stock-news.laohu8.com/highlight/detail?id=2459792250","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459792250?lang=zh_cn&edition=full","pubTime":"2024-08-16 14:18","pubTimestamp":1723789113,"startTime":"0","endTime":"0","summary":"8月15日晚间,康哲药业(HK00867,股价7.26港元,市值177.1亿港元)披露2024年中期业绩报告。今年上半年,公司实现营收36.11亿元,同比下降21.7%,环比增长6.1%;净利润为9.03亿元,同比下降52.8%,环比增长92.8%。康哲药业的黛力新进入第七批国采目录,波依定和优思弗进入第八批国采目录,这三款产品均未中标,对公司经营业绩产生较大的负面影响。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202408163157980251.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202408163157980251.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1191","SG9999015945.SGD","BK1593","SG9999015952.SGD","SG9999015978.USD","00867","LU2488822045.USD","SG9999015986.USD","SG9999004220.SGD"],"gpt_icon":0},{"id":"2459256906","title":"康哲药业(00867)2024年中期营业额和利润环比均稳步提升 迈入\"新产品时代\"","url":"https://stock-news.laohu8.com/highlight/detail?id=2459256906","media":"美通社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459256906?lang=zh_cn&edition=full","pubTime":"2024-08-16 11:53","pubTimestamp":1723780380,"startTime":"0","endTime":"0","summary":"2024年8月15日,康哲药业公布,2024年中期整体营业额和期间利润环比去年下半年稳步提升。2024年上半年,公司整体业绩环比去年下半年呈现增长态势,标志着康哲药业已基本消化国采影响,成功迈入由非国采独家产品和创新产品驱动业务增长的\"新产品时代\"。康哲药业亦稳步推进创新产品临床开发相关工作。业绩公告显示,截至6月底,康哲药业推广网络覆盖中国超5.5万家医院及医疗机构,约28万家终端零售药店。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://wwwold.prnasia.com/story/archive/4485472_ZH85472_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["00867","SG9999004220.SGD","SG9999015978.USD","BK1593","SG9999015952.SGD","SG9999015945.SGD","BK1191","SG9999015986.USD","LU2488822045.USD"],"gpt_icon":0},{"id":"2459125502","title":"康哲药业(00867.HK)绩后曾升11% 中期溢利较去年下半年增长近93%","url":"https://stock-news.laohu8.com/highlight/detail?id=2459125502","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459125502?lang=zh_cn&edition=full","pubTime":"2024-08-16 11:40","pubTimestamp":1723779600,"startTime":"0","endTime":"0","summary":"康哲药业股价延续昨日升势,今日高开3.6%报6.89元,早段曾升11.3%高见7.4元,创逾两个月高位。公司中期营业额36.11亿人民币(下同),按年下降21.7%,较去年下半年则升6.1%。若全按药品销售收入计算则营业额为42.88亿元,按年跌22.6%,较去年下半年升8.9%。股东应占纯利9.1亿元,倒退52.6%,每股盈利37.34分。期内,康哲药业的溢利为9.03亿元,按年跌52.8%,较去年下半年则升92.8%;若剔除计提资产减值损失的影响则期间溢利较去年下半年增长16.4%至9.23亿元。","market":"other","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20230222154139299_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20230222154139299_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1372241/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["SG9999015978.USD","SG9999015986.USD","SG9999015945.SGD","BK1593","00867","BK1191","SG9999015952.SGD","LU2488822045.USD","SG9999004220.SGD"],"gpt_icon":0},{"id":"2459523253","title":"康哲药业(00867)股价显著上升11.128%,现价港币$7.39","url":"https://stock-news.laohu8.com/highlight/detail?id=2459523253","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459523253?lang=zh_cn&edition=full","pubTime":"2024-08-16 10:03","pubTimestamp":1723773780,"startTime":"0","endTime":"0","summary":"[上升股]康哲药业(00867) 股价在上午10:03比前收市价显著上升11.128%,现股价为港币$7.39。至目前为止,今日最高价为$7.39,而最低价为$6.89。总成交量为862.7万股,总成交金额为港币$6.228千万。","market":"other","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180112133337750_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180112133337750_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2408161983/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1593","00867","SG9999015945.SGD","SG9999015986.USD","SG9999015978.USD","SG9999004220.SGD","BK1191","SG9999015952.SGD","LU2488822045.USD"],"gpt_icon":0},{"id":"2459923454","title":"康哲药业(00867)上涨10.08%,报7.32元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2459923454","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459923454?lang=zh_cn&edition=full","pubTime":"2024-08-16 09:51","pubTimestamp":1723773109,"startTime":"0","endTime":"0","summary":"8月16日,康哲药业盘中上涨10.08%,截至09:51,报7.32元/股,成交4885.21万元。康哲药业控股有限公司主要业务是与全球生物科技和制药公司合作,开发全球首创和同类最优的创新产品,专注于心脑血管、消化、中枢神经、皮肤/医美、眼科、儿科等专科疾病领域。截至2024年中报,康哲药业营业总收入36.11亿元、净利润9.1亿元。8月15日,2024财年中报归属股东应占溢利9.104亿人民币,同比下降52.61%,基本每股收益0.3734人民币。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/08/16095142415663.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["00867","SG9999004220.SGD","SG9999015945.SGD","SG9999015986.USD","BK1191","SG9999015978.USD","LU2488822045.USD","BK1593","SG9999015952.SGD"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.cms.net.cn","stockEarnings":[{"period":"1week","weight":0.1027},{"period":"1month","weight":0.0786},{"period":"3month","weight":0.0861},{"period":"6month","weight":-0.3741},{"period":"1year","weight":-0.3118},{"period":"ytd","weight":-0.4302}],"compareEarnings":[{"period":"1week","weight":0.0247},{"period":"1month","weight":0.0132},{"period":"3month","weight":-0.0418},{"period":"6month","weight":0.0473},{"period":"1year","weight":-0.0151},{"period":"ytd","weight":0.0359}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"康哲药业控股有限公司是一家主要从事医药产品的制造、推广、营销及销售业务的香港投资控股公司。其直接网络主要产品包括黛力新、优思弗、新活素、莎尔福、亿活及施图伦滴眼液等。其代理商推广网络产品包括沙多力卡、伊诺舒及喜达康等。其产品用于治疗胃病、心脏病、外伤感染、肝病及眼疾等。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.011301},{"month":2,"riseRate":0.538462,"avgChangeRate":0.023837},{"month":3,"riseRate":0.5,"avgChangeRate":0.004124},{"month":4,"riseRate":0.5,"avgChangeRate":0.02223},{"month":5,"riseRate":0.428571,"avgChangeRate":-0.008532},{"month":6,"riseRate":0.642857,"avgChangeRate":-0.002183},{"month":7,"riseRate":0.5,"avgChangeRate":-0.017299},{"month":8,"riseRate":0.428571,"avgChangeRate":0.023866},{"month":9,"riseRate":0.428571,"avgChangeRate":-0.012267},{"month":10,"riseRate":0.571429,"avgChangeRate":0.021736},{"month":11,"riseRate":0.571429,"avgChangeRate":0.062351},{"month":12,"riseRate":0.642857,"avgChangeRate":0.043928}],"exchange":"SEHK","name":"康哲药业","nameEN":"CMS"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.26.4","shortVersion":"4.26.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"康哲药业(00867)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供康哲药业(00867)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"康哲药业,00867,康哲药业股票,康哲药业股票老虎,康哲药业股票老虎国际,康哲药业行情,康哲药业股票行情,康哲药业股价,康哲药业股市,康哲药业股票价格,康哲药业股票交易,康哲药业股票购买,康哲药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"康哲药业(00867)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供康哲药业(00867)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}